Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Siezen CL"'
Autor:
Doorduyn Y, Van Pelt W, Siezen CL, Van Der Horst F, Van Duynhoven YT, Hoebee B, Janssen R, Doorduyn, Y, Van Pelt, W, Siezen, C L E, Van Der Horst, F, Van Duynhoven, Y T H P, Hoebee, B, Janssen, R
Publikováno v:
Epidemiology & Infection; Sep2008, Vol. 136 Issue 9, p1225-1234, 10p
Autor:
Theunissen PT; a Centre for Health Protection, National Institute for Public Health and the Environment (RIVM) , Bilthoven , The Netherlands.; b Medicines Evaluation Board , Utrecht , The Netherlands.; c Innovative Testing in Life Sciences and Chemistry , University of Applied Sciences Utrecht (HU) , Utrecht , The Netherlands., Beken S; d Federal Agency for Medicines and Health Products , Brussels , Belgium., Beyer B; e Sanofi U.S. Inc , Bridgewater , NJ , USA., Breslin WJ; f Lilly Research Laboratories, Lilly Corporate Center , Indianapolis , IN , USA., Cappon GD; g Pfizer Worldwide Research & Development , Groton , CT , USA., Chen CL; h ILSI-Health and Environmental Sciences Institute , Washington , DC , USA., Chmielewski G; i Covance Laboratories Inc , Greenfield , IN , USA., de Schaepdrijver L; j Preclinical Development & Safety , Beerse , Belgium., Enright B; k AbbVie Inc , North Chicago , IL , USA., Foreman JE; l ExxonMobil Biomedical Sciences, Inc , Annandale , NJ , USA., Harrouk W; m US Food & Drug Administration , Silver Spring , MD , USA., Hew KW; n Takeda Pharmaceutical Company , Deerfield , IL , USA., Hoberman AM; o Preclinical Services , Charles-River Laboratories , Horsham , PA , USA., Y Hui J; p Celgene Corporation , Summit , NJ , USA., Knudsen TB; q US Environmental Protection Agency, National Center for Computational Toxicology , Research Triangle Park , NC , USA., Laffan SB; r Safety Assessment , GlaxoSmithKline , King of Prussia , PA , USA., Makris SL; s National Center for Environmental Assessment, US Environmental Protection Agency , Washington , DC , USA., Martin M; q US Environmental Protection Agency, National Center for Computational Toxicology , Research Triangle Park , NC , USA., McNerney ME; t Drug Safety Evaluation , Bristol-Myers Squibb , New Brunswick , NJ , USA., Siezen CL; b Medicines Evaluation Board , Utrecht , The Netherlands., Stanislaus DJ; r Safety Assessment , GlaxoSmithKline , King of Prussia , PA , USA., Stewart J; u Drug Safety & Metabolism , AstraZeneca , Macclesfield , UK., Thompson KE; t Drug Safety Evaluation , Bristol-Myers Squibb , New Brunswick , NJ , USA., Tornesi B; k AbbVie Inc , North Chicago , IL , USA., Van der Laan JW; a Centre for Health Protection, National Institute for Public Health and the Environment (RIVM) , Bilthoven , The Netherlands.; b Medicines Evaluation Board , Utrecht , The Netherlands., Weinbauer GF; v Covance Preclinical Services GmbH , Muenster , Germany., Wood S; w Merck Research Laboratories , Upper Gwynedd , PA , USA., Piersma AH; a Centre for Health Protection, National Institute for Public Health and the Environment (RIVM) , Bilthoven , The Netherlands.; x Faculty of Veterinary Sciences , Institute for Risk Assessment Sciences, Utrecht University , Utrecht , The Netherlands.
Publikováno v:
Critical reviews in toxicology [Crit Rev Toxicol] 2017 May; Vol. 47 (5), pp. 402-414. Date of Electronic Publication: 2016 Oct 21.
Autor:
Ter Braak B; Division of Toxicology, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333, CC, Leiden, The Netherlands., Siezen CL; Medicines Evaluation Board (MEB), Graadt van Roggenweg 500, 3531, AH, Utrecht, The Netherlands., Lee JS; The Blavatnik School of Computer Science, Tel-Aviv University, Tel Aviv, 69978, Israel., Rao P; ServiceXS, Plesmanlaan 1 /D, 2333, BZ, Leiden, The Netherlands., Voorhoeve C; Division of Toxicology, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333, CC, Leiden, The Netherlands., Ruppin E; The Blavatnik School of Computer Science, Tel-Aviv University, Tel Aviv, 69978, Israel., van der Laan JW; Division of Toxicology, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333, CC, Leiden, The Netherlands. jw.vd.laan@cbg-meb.nl.; Medicines Evaluation Board (MEB), Graadt van Roggenweg 500, 3531, AH, Utrecht, The Netherlands. jw.vd.laan@cbg-meb.nl.; Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3721, MA, Bilthoven, The Netherlands. jw.vd.laan@cbg-meb.nl., van de Water B; Division of Toxicology, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333, CC, Leiden, The Netherlands. b.water@lacdr.leidenuniv.nl.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2017 Feb 07; Vol. 19 (1), pp. 14. Date of Electronic Publication: 2017 Feb 07.
Autor:
Theunissen PT; a Centre for Health Protection, National Institute for Public Health and the Environment (RIVM) , Bilthoven , The Netherlands.; b Medicines Evaluation Board , Utrecht , The Netherlands.; c Innovative Testing in Life Sciences and Chemistry, University of Applied Sciences Utrecht (HU) , Utrecht , The Netherlands., Beken S; d Federal Agency for Medicines and Health Products , Brussels , Belgium., Beyer BK; e Sanofi U.S. Inc. Bridgewater , NJ , USA., Breslin WJ; f Lilly Research Laboratories , Lilly Corporate Center , Indianapolis , IN , USA., Cappon GD; g Pfizer Worldwide Research & Development , Groton , CT , USA., Chen CL; h ILSI-Health and Environmental Sciences Institute , Washington , DC , USA., Chmielewski G; i Covance Laboratories Inc , Greenfield , IN , USA., De Schaepdrijver L; j Janssen R&D, Preclinical Development & Safety Beerse , Belgium., Enright B; k AbbVie Inc , North Chicago , IL , USA., Foreman JE; l ExxonMobil Biomedical Sciences, Inc , Annandale , NJ , USA., Harrouk W; m U.S. Food & Drug Administration , Silver Spring , MD , USA., Hew KW; n Takeda Pharmaceutical Company , Deerfield , IL , USA., Hoberman AM; o Charles-River Laboratories, Preclinical Services , Horsham , PA , USA., Hui JY; p Celgene Corporation , Summit , NJ , USA., Knudsen TB; q U.S. Environmental Protection Agency, National Center for Computational Toxicology, Research Triangle Park , NC , USA., Laffan SB; r Safety Assessment, GlaxoSmithKline , King of Prussia , PA , USA., Makris SL; s U.S. Environmental Protection Agency, National Center for Environmental Assessment , Washington , DC , USA., Martin M; q U.S. Environmental Protection Agency, National Center for Computational Toxicology, Research Triangle Park , NC , USA., McNerney ME; t Drug Safety Evaluation, Bristol-Myers Squibb , New Brunswick , NJ , USA., Siezen CL; b Medicines Evaluation Board , Utrecht , The Netherlands., Stanislaus DJ; r Safety Assessment, GlaxoSmithKline , King of Prussia , PA , USA., Stewart J; u Drug Safety & Metabolism, AstraZeneca , Macclesfield , UK., Thompson KE; t Drug Safety Evaluation, Bristol-Myers Squibb , New Brunswick , NJ , USA., Tornesi B; k AbbVie Inc , North Chicago , IL , USA., Van der Laan JW; a Centre for Health Protection, National Institute for Public Health and the Environment (RIVM) , Bilthoven , The Netherlands.; b Medicines Evaluation Board , Utrecht , The Netherlands., Weinbauer GF; v Covance Preclinical Services GmbH , Muenster , Germany., Wood S; w Merck Research Laboratories , Upper Gwynedd , Pennsylvania , USA., Piersma AH; a Centre for Health Protection, National Institute for Public Health and the Environment (RIVM) , Bilthoven , The Netherlands.; x Institute for Risk Assessment Sciences, Faculty of Veterinary Sciences , Utrecht University , Utrecht , The Netherlands.
Publikováno v:
Critical reviews in toxicology [Crit Rev Toxicol] 2016 Nov; Vol. 46 (10), pp. 900-910. Date of Electronic Publication: 2016 Oct 19.
Autor:
Bronsveld HK; Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. h.bronsveld@nki.nl.; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands. h.bronsveld@nki.nl., ter Braak B; Division of Toxicology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. basterbraak@gmail.com., Karlstad Ø; Department of Pharmacoepidemiology, Norwegian Institute of Public Health, Oslo, Norway. Oystein.Karlstad@fhi.no., Vestergaard P; Departments of Clinical Medicine and Endocrinology, Aalborg University, Aalborg, Denmark. p-vest@post4.tele.dk., Starup-Linde J; Departments of Clinical Medicine and Endocrinology, Aalborg University, Aalborg, Denmark. Jakob.Linde@auh.rm.dk.; Department of Endocrinology and Internal Medicine (MEA), Aarhus University Hospital THG, Aarhus, Denmark. Jakob.Linde@auh.rm.dk., Bazelier MT; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands. M.T.Bazelier@uu.nl., De Bruin ML; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands. M.L.deBruin@uu.nl., de Boer A; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands. a.deboer@uu.nl., Siezen CL; Medicines Evaluation Board (MEB), Utrecht, The Netherlands. cl.siezen@cbg-meb.nl., van de Water B; Division of Toxicology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. water_b@lacdr.leidenuniv.nl., van der Laan JW; Division of Toxicology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. jw.vd.laan@cbg-meb.nl.; Medicines Evaluation Board (MEB), Utrecht, The Netherlands. jw.vd.laan@cbg-meb.nl.; Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. jw.vd.laan@cbg-meb.nl., Schmidt MK; Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. mk.schmidt@nki.nl.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2015 Aug 05; Vol. 17, pp. 100. Date of Electronic Publication: 2015 Aug 05.
Autor:
ter Braak B; Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands., Siezen CL, Kannegieter N, Koedoot E, van de Water B, van der Laan JW
Publikováno v:
Archives of toxicology [Arch Toxicol] 2014 Apr; Vol. 88 (4), pp. 953-66. Date of Electronic Publication: 2014 Jan 25.
Autor:
Knopperts AP; Department of Genetics, University Medical Center Groningen, University of Groningen, Hanzeplein 1, P.O. Box 30001, 9700RB, Groningen, The Netherlands., Nielsen M, Niessen RC, Tops CM, Jorritsma B, Varkevisser J, Wijnen J, Siezen CL, Heine-Bröring RC, van Kranen HJ, Vos YJ, Westers H, Kampman E, Sijmons RH, Hes FJ
Publikováno v:
Familial cancer [Fam Cancer] 2013 Mar; Vol. 12 (1), pp. 43-50.
Autor:
Schuurhof A; Laboratory for Health Protection Research, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Bont L, Siezen CL, Hodemaekers H, van Houwelingen HC, Kimman TG, Hoebee B, Kimpen JL, Janssen R
Publikováno v:
Pediatric pulmonology [Pediatr Pulmonol] 2010 Jun; Vol. 45 (6), pp. 608-13.
Autor:
van den Berg SW; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. saskia.van.den.berg@rivm.nl, Dollé ME, Imholz S, van der A DL, van 't Slot R, Wijmenga C, Verschuren WM, Strien C, Siezen CL, Hoebee B, Feskens EJ, Boer JM
Publikováno v:
International journal of obesity (2005) [Int J Obes (Lond)] 2009 Oct; Vol. 33 (10), pp. 1143-52. Date of Electronic Publication: 2009 Aug 04.
Autor:
Siezen CL; Laboratory for Health Protection Research, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Bont L, Hodemaekers HM, Ermers MJ, Doornbos G, Van't Slot R, Wijmenga C, Houwelingen HC, Kimpen JL, Kimman TG, Hoebee B, Janssen R
Publikováno v:
The Pediatric infectious disease journal [Pediatr Infect Dis J] 2009 Apr; Vol. 28 (4), pp. 333-5.